StreetInsider.com News Articles

Clearway Energy names new CFO and controller amid leadership shuffle

Tue, 08 Sep 2026 16:30:19 -0400

Clearway Energy, Inc. (NYSE: CWEN) announced a series of senior leadership changes, including a new chief financial officer and a new controller, effective October 1, 2026, according to a company statement.

Steven Ryder will become CFO of Clearway Energy, Inc., succeeding Sarah Rubenstein, who is moving to a newly created role as Head of the Transformation Office at Clearway Energy Group LLC. In that role, Rubenstein will focus on digital and data transformation, including the use of automation and artificial intelligence. Ryder will retain his existing position as CFO of Clearway Energy Group.

Ryder has served as CFO of Clearway Energy Group

Clearway Energy names new CFO and controller amid leadership shuffle

Tue, 08 Sep 2026 16:30:19 -0400

Ryder has served as CFO of Clearway Energy Group

Clearway Energy, Inc. Announces Senior Leadership Changes

Tue, 08 Sep 2026 16:30:00 -0400

PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN) (“Company”, “Clearway”) today announced a series of senior leadership appointments:

Sarah Rubenstein, Chief Financial Officer (“CFO”) of Clearway Energy, Inc., will move into a new role at Clearway Energy Group LLC (“Clearway Group”) as the Head of the Transformation Office focusing on digital and data transformation and integration activities, effective October 1, 2026.
Steven Ryder, will succeed Ms. Rubenstein as Clearway Energy, Inc.’s CFO effective October 1, 2026, and will maintain his role as CFO of Clearway Group; and
Samantha Prout, will join the Company as Senior Vice President,

Clearway Energy, Inc. Announces Senior Leadership Changes

Tue, 08 Sep 2026 16:30:00 -0400

PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN) (“Company”, “Clearway”) today announced a series of senior leadership appointments:

Sarah Rubenstein, Chief Financial Officer (“CFO”) of Clearway Energy, Inc., will move into a new role at Clearway Energy Group LLC (“Clearway Group”) as the Head of the Transformation Office focusing on digital and data transformation and integration activities, effective October 1, 2026.
Steven Ryder, will succeed Ms. Rubenstein as Clearway Energy, Inc.’s CFO effective October 1, 2026, and will maintain his role as CFO of Clearway Group; and
Samantha Prout, will join the Company as Senior Vice President,

Clearway Energy, Inc. Announces Senior Leadership Changes

Tue, 08 Sep 2026 16:30:00 -0400

PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN) (“Company”, “Clearway”) today announced a series of senior leadership appointments:

Sarah Rubenstein, Chief Financial Officer (“CFO”) of Clearway Energy, Inc., will move into a new role at Clearway Energy Group LLC (“Clearway Group”) as the Head of the Transformation Office focusing on digital and data transformation and integration activities, effective October 1, 2026.
Steven Ryder, will succeed Ms. Rubenstein as Clearway Energy, Inc.’s CFO effective October 1, 2026, and will maintain his role as CFO of Clearway Group; and
Samantha Prout, will join the Company as Senior Vice President,

Clearway Energy, Inc. Announces Senior Leadership Changes

Tue, 08 Sep 2026 16:30:00 -0400

PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN) (“Company”, “Clearway”) today announced a series of senior leadership appointments:

Sarah Rubenstein, Chief Financial Officer (“CFO”) of Clearway Energy, Inc., will move into a new role at Clearway Energy Group LLC (“Clearway Group”) as the Head of the Transformation Office focusing on digital and data transformation and integration activities, effective October 1, 2026.
Steven Ryder, will succeed Ms. Rubenstein as Clearway Energy, Inc.’s CFO effective October 1, 2026, and will maintain his role as CFO of Clearway Group; and
Samantha Prout, will join the Company as Senior Vice President,

Form SCHEDULE 13G AMICUS THERAPEUTICS, Filed by: UBS Group AG

Thu, 07 May 2026 11:28:00 -0400

si-local-file:///var/storage/secattach/20260507/26450942.html

Form SCHEDULE 13G AMICUS THERAPEUTICS, Filed by: UBS Group AG

Thu, 07 May 2026 11:28:00 -0400

si-local-file:///var/storage/secattach/20260507/26450942.html

Form 15-12G AMICUS THERAPEUTICS,

Thu, 07 May 2026 08:39:00 -0400

si-local-file:///var/storage/secattach/20260507/26449315.html

Form 15-12G AMICUS THERAPEUTICS,

Thu, 07 May 2026 08:39:00 -0400

si-local-file:///var/storage/secattach/20260507/26449315.html

Form SCHEDULE 13G AMICUS THERAPEUTICS, Filed by: GLAZER CAPITAL, LLC

Fri, 01 May 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260501/26418059.html

Form SCHEDULE 13G AMICUS THERAPEUTICS, Filed by: GLAZER CAPITAL, LLC

Fri, 01 May 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260501/26418059.html

Form EFFECT AMICUS THERAPEUTICS,